Ohwada M - Search Results

1

Combination therapy of tyrosine kinase receptor inhibitor TSU-68 (SU6668) and paclitaxel inhibits subcutaneous xenografts of endometrial cancer.

Machida S, Saga Y, Takei Y, Takahashi K, Nonaka H, Fujiwara H, Ohwada M, Suzuki M. Machida S, et al. Among authors: ohwada m. Mol Med Rep. 2008 Nov-Dec;1(6):843-6. doi: 10.3892/mmr_00000038. Mol Med Rep. 2008. PMID: 21479494

2

Thymidylate synthase activity in normal and malignant gynecologic tissues.

Suzuki M, Ohwada M, Tamada T. Suzuki M, et al. Among authors: ohwada m. Asia Oceania J Obstet Gynaecol. 1992 Dec;18(4):379-85. doi: 10.1111/j.1447-0756.1992.tb00334.x. Asia Oceania J Obstet Gynaecol. 1992. PMID: 1492811

3

Clinical value of sialyl SSEA-1 antigen in patients with ovarian cancer.

Suzuki M, Ohwada M, Tamada T. Suzuki M, et al. Among authors: ohwada m. Gynecol Oncol. 1990 Mar;36(3):371-5. doi: 10.1016/0090-8258(90)90145-b. Gynecol Oncol. 1990. PMID: 1969379

4

[Clinical value of a new serum tumor marker CA602 in ovarian cancers].

Suzuki M, Sekiguchi I, Ohwada M, Aida I, Tamada T. Suzuki M, et al. Among authors: ohwada m. Nihon Gan Chiryo Gakkai Shi. 1990 Jul 20;25(7):1454-60. Nihon Gan Chiryo Gakkai Shi. 1990. PMID: 2170549 Japanese.

5

[Immunohistochemical investigation of vimentin of uterine endometrial and endocervical adenocarcinoma].

Ohwada M, Suzuki M, Tamada T. Ohwada M, et al. Nihon Sanka Fujinka Gakkai Zasshi. 1990 Sep;42(9):1237-43. Nihon Sanka Fujinka Gakkai Zasshi. 1990. PMID: 2212824 Japanese.

6

Plasma prostaglandin levels in patients with gynecologic malignancies and its fluctuations during chemotherapeutically-induced gastrointestinal toxicity.

Suzuki M, Ohwada M, Tamada T. Suzuki M, et al. Among authors: ohwada m. Jpn J Clin Oncol. 1987 Sep;17(3):215-20. Jpn J Clin Oncol. 1987. PMID: 3478510

7

Serum level of macrophage colony-stimulating factor as a marker for gynecologic malignancies.

Suzuki M, Ohwada M, Sato I, Nagatomo M. Suzuki M, et al. Among authors: ohwada m. Oncology. 1995 Mar-Apr;52(2):128-33. doi: 10.1159/000227443. Oncology. 1995. PMID: 7854772

8

[5-FU concentrations in the blood and tumor tissue after 5'-DFUR or UFT administration in the patients with uterine cervical cancer].

Suzuki M, Aida I, Ohwada M, Sato I, Tamura T, Kasuga Y. Suzuki M, et al. Among authors: ohwada m. Gan To Kagaku Ryoho. 1995 Feb;22(2):253-8. Gan To Kagaku Ryoho. 1995. PMID: 7857101 Clinical Trial. Japanese.

9

Macrophage colony-stimulating factor enhances platelet recovery following cisplatin/carboplatin chemotherapy in ovarian cancer.

Suzuki M, Ohwada M, Aida I, Sato I, Tamada T. Suzuki M, et al. Among authors: ohwada m. Gynecol Oncol. 1994 Jul;54(1):23-6. doi: 10.1006/gyno.1994.1160. Gynecol Oncol. 1994. PMID: 8020834

10

Thymidylate synthase activity as a prognostic factor in ovarian cancer.

Suzuki M, Ohwada M, Tamada T, Tsuru S. Suzuki M, et al. Among authors: ohwada m. Oncology. 1994 Jul-Aug;51(4):334-8. doi: 10.1159/000227360. Oncology. 1994. PMID: 8208516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters